BriaCell Therapeutics (BCTXW) News Today → The Next Nvidia? (From InvestorPlace) (Ad) Free BCTXW Stock Alerts $0.95 -0.01 (-1.04%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGet Rich Quick With These 3 Penny Stocks to Buy Nowfinance.yahoo.com - February 20 at 9:51 AMBriaCell Therapeutics Corp.: BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Casefinanznachrichten.de - February 7 at 10:32 AMBreaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturingfinance.yahoo.com - February 6 at 9:16 AMBriaCell Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (BCT)theglobeandmail.com - January 6 at 1:21 PMBriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancerfinance.yahoo.com - January 4 at 9:08 AMBriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefitfinance.yahoo.com - December 6 at 9:47 AMBriaCell Therapeutics Corp.: BriaCell Records New Responder with Remarkable Improvement of "Eye-Bulging" Metastatic Tumorfinanznachrichten.de - November 30 at 9:40 AMBriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumorfinance.yahoo.com - November 30 at 9:40 AMBriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferencesfinance.yahoo.com - October 18 at 12:37 PMBriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast Cancerfinance.yahoo.com - October 4 at 9:26 AMBriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing Shareholdersfinance.yahoo.com - August 25 at 3:43 PMBriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp.finance.yahoo.com - May 25 at 9:41 AMBriaCell Presents Positive Data Demonstrating Survival and Clinical Benefits in Advanced Metastatic Breast Cancer at the 2023 AACRfinance.yahoo.com - April 17 at 8:39 AMBriaCell intends to launch a spinoff to accelerate its drug development activitiesbizjournals.com - April 3 at 1:58 PMBriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual Meetingfinance.yahoo.com - March 15 at 9:34 AMBriaCell Therapeutics Corp.: BriaCell to Investigate Alleged Illegal Trading of Public Securitiesfinanznachrichten.de - January 23 at 2:41 PMBriaCell Announces New Patent Issuance, Bria-OTS™ IND Timing Guidance, and Additional Clinical Sites to Boost Enrolmentfinance.yahoo.com - January 10 at 10:26 AMBriaCell Announces Positive Clinical and Quality of Life Data in Advanced Metastatic Breast Cancer at 2022 San Antonio Breast Cancer Symposium®finance.yahoo.com - December 8 at 2:45 PMBriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation Progressingfinance.yahoo.com - October 21 at 9:15 AMBriaCell Secures License for a Promising Novel Anti-Cancer Agentfinance.yahoo.com - August 4 at 9:27 AMBriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatmentfinance.yahoo.com - June 29 at 9:27 AM Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story BCTXW Media Mentions By Week BCTXW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCTXW News Sentiment▼0.000.49▲Average Medical News Sentiment BCTXW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCTXW Articles This Week▼00▲BCTXW Articles Average Week Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alpha Tau Medical News Today Artelo Biosciences News Today eFFECTOR Therapeutics News Today Fortress Biotech News Today GeoVax Labs News Today NLS Pharmaceutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCTXW) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressThe “Perfect Storm” for GoldGold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.